ANRIL Genetic Variants in Iranian Breast Cancer Patients

(Pages: 72-78)
Hamid Reza Khorshidi, M.D, 1Mohammad Taheri, M.Sc, 2Rezvan Noroozi, M.Sc, 2Shaghayegh Sarrafzadeh, M.Sc, 2Arezou Sayad, Ph.D, 2,*Soudeh Ghafouri-Fard, M.D., Ph.D, 2,*
Department of Surgery, Hamadan University of Medical Sciences, Hamadan, Iran
Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Surgery, Hamadan University of Medical Sciences, Hamadan, Iran
Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*Corresponding Address: P.O.Box: 19857-17443 Department of Medical Genetics Faculty of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran Emails:ar.sayad@yahoo.com,s.ghafourifard@sbmu.ac.ir
Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Khorshidi Hamid Reza, Taheri Mohammad, Noroozi Rezvan, Sarrafzadeh Shaghayegh, Sayad Arezou, Ghafouri-Fard Soudeh. ANRIL Genetic Variants in Iranian Breast Cancer Patients. Cell J. 2017; 19(Suppl 1): 72-78.

Abstract

Objective

The genetic variants of the long non-coding RNA ANRIL (an antisense noncoding RNA in the INK4 locus) as well as its expression have been shown to be associated with several human diseases including cancers. The aim of this study was to examine the association of ANRIL variants with breast cancer susceptibility in Iranian patients.

Materials and Methods

In this case-control study, we genotyped rs1333045, rs4977574, rs1333048 and rs10757278 single nucleotide polymorphisms (SNPs) in 122 breast can- cer patients as well as in 200 normal age-matched subjects by tetra-primer amplification refractory mutation system polymerase chain reaction (T-ARMS-PCR).

Results

The TT genotype at rs1333045 was significantly over-represented among pa- tients (P=0.038) but did not remain significant after multiple-testing correction. In addi- tion, among all observed haplotypes (with SNP order of rs1333045, rs1333048 rs4977574 and rs10757278), four haplotypes were shown to be associated with breast cancer risk. However, after multiple testing corrections, TCGA was the only haplotype which remained significant.

Conclusion

These results suggest that breast cancer risk is significantly associated with ANRIL variants. Future work analyzing the expression of different associated ANRIL haplotypes would further shed light on the role of ANRIL in this disease.